NephroGenex, Inc. Additional Paid in Capital
NephroGenex, Inc. had Additional Paid in Capital of $91.82 million as of 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2016-03-29
- 2015-12-31: Additional Paid in Capital $91.82M.
- 2015-09-30: Additional Paid in Capital $86.14M.
- 2015-06-30: Additional Paid in Capital $77.73M.
- 2015-03-31: Additional Paid in Capital $77.42M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2015-12-31 | $91.82M 10-K · filed 2016-03-29 | |
| 2015-09-30 | $86.14M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $77.73M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $77.42M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $77.15M 10-K · filed 2016-03-29 | |
| 2014-09-30 | $76.73M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $76.55M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $76.11M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $26.79M 10-K · filed 2015-03-24 | $26.79M 10-Q · filed 2014-05-14 |